• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病和健康对照者中[F]florbetapir 成像的参数方法重复性:一项测试-重测研究。

Repeatability of parametric methods for [F]florbetapir imaging in Alzheimer's disease and healthy controls: A test-retest study.

机构信息

Department of Radiology & Nuclear Medicine, Amsterdam University Medical center location VUmc, The Netherlands.

Neurology & Alzheimer Center, Amsterdam Neuroscience, Amsterdam University Medical center location VUmc, The Netherlands.

出版信息

J Cereb Blood Flow Metab. 2021 Mar;41(3):569-578. doi: 10.1177/0271678X20915403. Epub 2020 Apr 22.

DOI:10.1177/0271678X20915403
PMID:32321347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907981/
Abstract

Accumulation of amyloid beta (Aβ) is one of the pathological hallmarks of Alzheimer's disease (AD), which can be visualized using [F]florbetapir positron emission tomography (PET). The aim of this study was to evaluate various parametric methods and to assess their test-retest (TRT) reliability. Two 90 min dynamic [F]florbetapir PET scans, including arterial sampling, were acquired ( = 8 AD patient,  = 8 controls). The following parametric methods were used; (reference:cerebellum); Logan and spectral analysis (SA), receptor parametric mapping (RPM), simplified reference tissue model2 (SRTM2), reference Logan (rLogan) and standardized uptake value ratios (SUV). BP+1, DVR, V and SUVr were compared with corresponding estimates (V or DVR) from the plasma input reversible two tissue compartmental (2T4k_V) model with corresponding TRT values for 90-scan duration. RPM ( = 0.92; slope = 0.91), Logan ( = 0.95; slope = 0.84) and rLogan ( = 0.94; slope = 0.88), and SRTM2 ( = 0.91; slope = 0.83), SA ( = 0.91; slope = 0.88), SUVr ( = 0.84; slope = 1.16) correlated well with their 2T4k_V counterparts. RPM (controls: 1%, AD: 3%), rLogan (controls: 1%, AD: 3%) and SUV (controls: 3%, AD: 8%) showed an excellent TRT reliability. In conclusion, most parametric methods showed excellent performance for [F]florbetapir, but RPM and rLogan seem the methods of choice, combining the highest accuracy and best TRT reliability.

摘要

淀粉样蛋白 β (Aβ) 的积累是阿尔茨海默病 (AD) 的病理标志之一,可以通过 [F]florbetapir 正电子发射断层扫描 (PET) 进行可视化。本研究旨在评估各种参数方法,并评估它们的测试-重测 (TRT) 可靠性。进行了两次 90 分钟的动态 [F]florbetapir PET 扫描,包括动脉采样 ( = 8 名 AD 患者, = 8 名对照)。使用了以下参数方法:(参考:小脑);Logan 和谱分析 (SA)、受体参数映射 (RPM)、简化参考组织模型 2 (SRTM2)、参考 Logan (rLogan) 和标准化摄取值比 (SUV)。BP+1、DVR、V 和 SUVr 与相应的血浆输入可逆两组织隔室 (2T4k_V) 模型的估计值 (V 或 DVR) 进行了比较,并与 90 分钟扫描持续时间的相应 TRT 值进行了比较。RPM ( = 0.92;斜率 = 0.91)、Logan ( = 0.95;斜率 = 0.84) 和 rLogan ( = 0.94;斜率 = 0.88),以及 SRTM2 ( = 0.91;斜率 = 0.83)、SA ( = 0.91;斜率 = 0.88)、SUVr ( = 0.84;斜率 = 1.16) 与 2T4k_V 对应的方法相关性良好。RPM (对照:1%,AD:3%)、rLogan (对照:1%,AD:3%) 和 SUV (对照:3%,AD:8%) 显示出优异的 TRT 可靠性。总之,大多数参数方法对 [F]florbetapir 表现出优异的性能,但 RPM 和 rLogan 似乎是最佳选择,结合了最高的准确性和最佳的 TRT 可靠性。

相似文献

1
Repeatability of parametric methods for [F]florbetapir imaging in Alzheimer's disease and healthy controls: A test-retest study.阿尔茨海默病和健康对照者中[F]florbetapir 成像的参数方法重复性:一项测试-重测研究。
J Cereb Blood Flow Metab. 2021 Mar;41(3):569-578. doi: 10.1177/0271678X20915403. Epub 2020 Apr 22.
2
Quantification of [F]florbetapir: A test-retest tracer kinetic modelling study.[F]氟替卡滨的定量:一项重测示踪剂动力学建模研究。
J Cereb Blood Flow Metab. 2019 Nov;39(11):2172-2180. doi: 10.1177/0271678X18783628. Epub 2018 Jun 13.
3
Test-retest repeatability of [F]Flortaucipir PET in Alzheimer's disease and cognitively normal individuals.阿尔茨海默病患者和认知正常个体中[F]Flortaucipir PET 的重测重复性。
J Cereb Blood Flow Metab. 2020 Dec;40(12):2464-2474. doi: 10.1177/0271678X19879226. Epub 2019 Oct 1.
4
Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.(S)-¹⁸F-THK5117 作为评估 Tau 病理学的 PET 示踪剂的示踪动力学分析。
J Nucl Med. 2016 Apr;57(4):574-81. doi: 10.2967/jnumed.115.158519. Epub 2016 Jan 21.
5
Parametric imaging of dual-time window [F]flutemetamol and [F]florbetaben studies.双时窗 [F]氟替美莫和 [F]氟比洛芬的参数成像研究。
Neuroimage. 2021 Jul 1;234:117953. doi: 10.1016/j.neuroimage.2021.117953. Epub 2021 Mar 21.
6
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).使用放射性配体 18F-AV-45(florbetapir [校正] F 18)对阿尔茨海默病中的淀粉样蛋白沉积进行体内成像。
J Nucl Med. 2010 Jun;51(6):913-20. doi: 10.2967/jnumed.109.069088.
7
Effect of Shortening the Scan Duration on Quantitative Accuracy of [F]Flortaucipir Studies.缩短扫描时间对 [F]Flortaucipir 研究定量准确性的影响。
Mol Imaging Biol. 2021 Aug;23(4):604-613. doi: 10.1007/s11307-021-01581-5. Epub 2021 Jan 26.
8
18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.18F-氟代贝他匹PET在额颞叶痴呆和阿尔茨海默病患者中的应用
J Nucl Med. 2015 Mar;56(3):386-91. doi: 10.2967/jnumed.114.147454. Epub 2015 Feb 5.
9
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.阿尔茨海默病患者和认知正常受试者中氟[18F]氟比他滨 F 18 淀粉样蛋白 PET 的性能特征。
J Nucl Med. 2012 Mar;53(3):378-84. doi: 10.2967/jnumed.111.090340. Epub 2012 Feb 13.
10
Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [F]Flortaucipir and [F]Florbetapir Brain PET Studies.用于验证先前验证的参考区域在 [F]Flortaucipir 和 [F]Florbetapir 脑 PET 研究中使用的非侵入性标准化摄取值。
Mol Imaging Biol. 2021 Aug;23(4):550-559. doi: 10.1007/s11307-020-01572-y. Epub 2021 Jan 14.

引用本文的文献

1
Head to head comparison of two PET/CT imaging agents, [F]D3FSP ([F]P16-129) and [F]AV45, in patients with alzheimer's disease.两种PET/CT成像剂[F]D3FSP([F]P16 - 129)和[F]AV45在阿尔茨海默病患者中的头对头比较。
EJNMMI Res. 2025 Jun 22;15(1):77. doi: 10.1186/s13550-025-01276-w.
2
Quantitative Brain Amyloid PET.定量脑淀粉样 PET。
J Nucl Med. 2024 May 1;65(5):670-678. doi: 10.2967/jnumed.123.265766.
3
Kinetic analysis of cardiac dynamic F-Florbetapir PET in healthy volunteers and amyloidosis patients: A pilot study.

本文引用的文献

1
Assessing Amyloid Pathology in Cognitively Normal Subjects Using F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods.使用 F-Flutemetamol PET 评估认知正常受试者的淀粉样蛋白病理学:比较视觉解读和定量方法。
J Nucl Med. 2019 Apr;60(4):541-547. doi: 10.2967/jnumed.118.211532. Epub 2018 Oct 12.
2
Quantification of [F]florbetapir: A test-retest tracer kinetic modelling study.[F]氟替卡滨的定量:一项重测示踪剂动力学建模研究。
J Cereb Blood Flow Metab. 2019 Nov;39(11):2172-2180. doi: 10.1177/0271678X18783628. Epub 2018 Jun 13.
3
Forward to the Past: The Case for Quantitative PET Imaging.
健康志愿者和淀粉样变性患者心脏动态F-氟代硼替吡PET的动力学分析:一项初步研究。
Heliyon. 2024 Feb 10;10(4):e26021. doi: 10.1016/j.heliyon.2024.e26021. eCollection 2024 Feb 29.
4
Head-to-head comparison of relative cerebral blood flow derived from dynamic [F]florbetapir and [F]flortaucipir PET in subjects with subjective cognitive decline.主观认知衰退受试者中,动态[F]氟比他派和[F]氟 tau 西匹 PET 衍生的相对脑血流量的头对头比较。
EJNMMI Res. 2023 Oct 27;13(1):93. doi: 10.1186/s13550-023-01041-x.
5
NiftyPAD - Novel Python Package for Quantitative Analysis of Dynamic PET Data.NiftyPAD - 用于动态 PET 数据定量分析的新型 Python 包。
Neuroinformatics. 2023 Apr;21(2):457-468. doi: 10.1007/s12021-022-09616-0. Epub 2023 Jan 9.
6
Longitudinal change in ATN biomarkers in cognitively normal individuals.认知正常个体中 ATN 生物标志物的纵向变化。
Alzheimers Res Ther. 2022 Sep 3;14(1):124. doi: 10.1186/s13195-022-01069-6.
7
Quantification of amyloid PET for future clinical use: a state-of-the-art review.用于未来临床应用的淀粉样 PET 的量化:最新综述。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3508-3528. doi: 10.1007/s00259-022-05784-y. Epub 2022 Apr 7.
穿越时空:正电子发射断层显像术的定量研究。
J Nucl Med. 2017 Jul;58(7):1019-1024. doi: 10.2967/jnumed.116.188029. Epub 2017 May 18.
4
Validation of the Semiquantitative Static SUVR Method for F-AV45 PET by Pharmacokinetic Modeling with an Arterial Input Function.通过使用动脉输入函数的药代动力学建模对F-AV45 PET的半定量静态标准化摄取值(SUVR)方法进行验证
J Nucl Med. 2017 Sep;58(9):1483-1489. doi: 10.2967/jnumed.116.184481. Epub 2017 Mar 23.
5
Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.PET淀粉样配体[(18)F]氟替莫尔的参数成像与定量分析。
Neuroimage. 2015 Nov 1;121:184-92. doi: 10.1016/j.neuroimage.2015.07.037. Epub 2015 Jul 22.
6
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.痴呆综合征中淀粉样蛋白PET阳性的患病率:一项荟萃分析。
JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669.
7
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?阿尔茨海默病和额颞叶痴呆中的脑灌注与葡萄糖代谢:同一硬币的两面?
Eur Radiol. 2015 Oct;25(10):3050-9. doi: 10.1007/s00330-015-3696-1. Epub 2015 Apr 22.
8
Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.跨阿尔茨海默病谱系的β-淀粉样蛋白阶段的临床病理特征及11C-匹兹堡化合物B的意义
Brain. 2015 May;138(Pt 5):1370-81. doi: 10.1093/brain/awv050. Epub 2015 Mar 23.
9
Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.使用18F-氟代贝他吡PET和标准化摄取值比率测量纵向β-淀粉样蛋白变化。
J Nucl Med. 2015 Apr;56(4):567-74. doi: 10.2967/jnumed.114.148981. Epub 2015 Mar 5.
10
Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease.脑脊液 Ab42 和氟比洛芬 PET 对阿尔茨海默病的诊断准确性。
Ann Clin Transl Neurol. 2014 Aug;1(8):534-43. doi: 10.1002/acn3.81. Epub 2014 Jul 19.